PP2A and tumor radiotherapy
Authors:
Open Access
- 26 August 2020
- journal article
- review article
- Published by Springer Nature in Hereditas
- Vol. 157 (1) , 1-6
Abstract
Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that serves as a key regulator of cellular physiology in the context of apoptosis, mitosis, and DNA damage responses. Canonically, PP2A functions as a tumor suppressor gene. However, recent evidence suggests that inhibiting PP2A activity in tumor cells may represent a viable approach to enhancing tumor sensitivity to chemoradiotherapy as such inhibition can cause cells to enter a disordered mitotic state that renders them more susceptible to cell death. Indeed, there is evidence that inhibiting PP2A can slow tumor growth following radiotherapy in a range of cancer types including ovarian cancer, liver cancer, malignant glioma, pancreatic cancer, and nasopharyngeal carcinoma. In the present review, we discuss current understanding of the role of PP2A in tumor radiotherapy and the potential mechanisms whereby it may influence this process.Keywords
This publication has 90 references indexed in Scilit:
- PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cellsJournal of Clinical Investigation, 2013
- Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancerCancer Letters, 2013
- PP2A:B56ϵ, a Substrate of Caspase-3, Regulates p53-dependent and p53-independent Apoptosis during DevelopmentJournal of Biological Chemistry, 2010
- Protein phosphatase 2A has an essential role in the activation of γ-irradiation-induced G2/M checkpoint responseOncogene, 2010
- Protein Phosphatase 2A Regulates Interleukin-2 Receptor Complex Formation and JAK3/STAT5 ActivationJournal of Biological Chemistry, 2010
- Raf-independent, PP2A-dependent MEK activation in response to ERK silencingBiochemical and Biophysical Research Communications, 2009
- Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 bindingBlood, 2009
- A specific PP2A regulatory subunit, B56γ, mediates DNA damage‐induced dephosphorylation of p53 at Thr55The EMBO Journal, 2007
- Greatwall kinaseJournal of Cell Biology, 2004
- Ciliary Neurotrophic Factor Induced Increase in β-Amyloid Precursor Protein mRNA in Rat C6 Glioma CellsBiochemical and Biophysical Research Communications, 1994